ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 195,97
0,35%
Dow Jones
39 809,11
-0,49%
DAX
18 768,96
0,33%
Brent Oil
83,535
-0,07%
Bitcoin
69 900,52
5,50%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Harmony Biosciences Holdings Inc (HRMY)

  7. Harmony Biosciences Holdings Inc (HRMY) Actualités

HRMY

Harmony Biosciences (HRMY)

Harmony Biosciences Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:HRMY
DateHeureSourceTitreSymboleSociété
30/04/202413h05GlobeNewswire Inc.Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare EpilepsyNASDAQ:HRMYHarmony Biosciences Holdings Inc
30/04/202413h00PR Newswire (US)Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS AssetsNASDAQ:HRMYHarmony Biosciences Holdings Inc
16/04/202414h05PR Newswire (US)HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024NASDAQ:HRMYHarmony Biosciences Holdings Inc
11/04/202414h05PR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONISTNASDAQ:HRMYHarmony Biosciences Holdings Inc
03/04/202414h05PR Newswire (US)HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROMENASDAQ:HRMYHarmony Biosciences Holdings Inc
26/03/202413h05PR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
11/03/202422h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
08/03/202422h21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
28/02/202423h16Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:HRMYHarmony Biosciences Holdings Inc
28/02/202414h05PR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCESNASDAQ:HRMYHarmony Biosciences Holdings Inc
22/02/202422h14Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:HRMYHarmony Biosciences Holdings Inc
22/02/202414h00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:HRMYHarmony Biosciences Holdings Inc
22/02/202413h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRMYHarmony Biosciences Holdings Inc
22/02/202413h30GlobeNewswire Inc.Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business UpdatesNASDAQ:HRMYHarmony Biosciences Holdings Inc
21/02/202414h05PR Newswire (US)U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSYNASDAQ:HRMYHarmony Biosciences Holdings Inc
20/02/202414h05PR Newswire (US)HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROMENASDAQ:HRMYHarmony Biosciences Holdings Inc
14/02/202401h06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HRMYHarmony Biosciences Holdings Inc
08/02/202414h05PR Newswire (US)HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024NASDAQ:HRMYHarmony Biosciences Holdings Inc
26/01/202422h58Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
08/01/202414h05PR Newswire (US)HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT; PROVIDES 2024 NET PRODUCT REVENUE GUIDANCENASDAQ:HRMYHarmony Biosciences Holdings Inc
03/01/202414h05PR Newswire (US)HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
07/12/202322h06Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:HRMYHarmony Biosciences Holdings Inc
07/12/202314h05PR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT IN ADULT PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1NASDAQ:HRMYHarmony Biosciences Holdings Inc
05/12/202314h05PR Newswire (US)HARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY IN 22Q11.2 DELETION SYNDROME AT AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETINGNASDAQ:HRMYHarmony Biosciences Holdings Inc
16/11/202314h05PR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th ANNUAL HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
15/11/202314h05PR Newswire (US)HARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING COMPANIES IN NORTH AMERICA ON THE 2023 DELOITTE TECHNOLOGY FAST 500™NASDAQ:HRMYHarmony Biosciences Holdings Inc
08/11/202314h05PR Newswire (US)HARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD OF DIRECTORSNASDAQ:HRMYHarmony Biosciences Holdings Inc
31/10/202313h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HRMYHarmony Biosciences Holdings Inc
31/10/202312h30GlobeNewswire Inc.Harmony Biosciences Reports Strong Third Quarter 2023 Financial ResultsNASDAQ:HRMYHarmony Biosciences Holdings Inc
26/10/202314h05PR Newswire (US)HARMONY BIOSCIENCES SHOWCASES THE NEWEST PATIENTS AT THE HEART AND PROGRESS AT THE HEART AWARD RECIPIENTSNASDAQ:HRMYHarmony Biosciences Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:HRMY

Dernières Valeurs Consultées

NASDAQ
GOOGL
Alphabet
NASDAQ
AAPL
Apple
EU
EN
Bouygues
COIN
ETHUSD
Ethereum
FTSE
UKX
FTSE 100
NYSE
JPM
JP Morgan Chase
EU
BNP
BNP Paribas
SPI
SP500
S&P 500
NYSE
DIS
Walt Disney
EU
RNO
Renault
EU
VK
Vallourec
NASDAQ
AMZN
Amazon.com
EU
AI
Air Liquide
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés